+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Multiplex PCR Panel Testing Market Size, Share & Trends Analysis Report by Disease Application, Testing Setting, Throughput, End Use, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • May 2026
  • Region: Global
  • Grand View Research
  • ID: 6246131
REQUEST CUSTOMIZATION
Description Jump to:
The global multiplex PCR panel testing market size was estimated at USD 2.58 billion in 2025 and is projected to reach USD 4.86 billion by 2033, registering a CAGR of 8.42% from 2026 to 2033. The market growth is driven by the growing prevalence of respiratory and gastrointestinal infections and strong demand for rapid syndromic testing in infectious disease diagnostics.

Moreover, advancements in multiplexing technologies, laboratory automation, and high-throughput molecular workflows are supporting broader adoption of multiplex PCR panels across healthcare settings. Expanding utilization of decentralized and point-of-care molecular diagnostic platforms is further contributing to market growth.

The rising prevalence of respiratory and gastrointestinal infections is driving market growth due to growing demand for rapid and accurate pathogen identification. Multiplex PCR panel enables simultaneous detection of multiple viral, bacterial, and parasitic pathogens from a single sample, making them well-suited for managing infections associated with overlapping clinical symptoms. The growing incidence of respiratory infections, including influenza, RSV, pneumonia, and other lower respiratory tract infections, along with outbreaks of gastrointestinal infections such as norovirus and Shigella, is accelerating the adoption of syndromic molecular diagnostics across hospitals and clinical laboratories. According to a study published in The Lancet in September 2024, Global Burden of Disease analyses estimated that lower respiratory infections accounted for approximately 344 million cases globally and continued to rank among the leading infectious causes of mortality worldwide. Moreover, the Centers for Disease Control and Prevention reported in April 2026 that nearly 2,500 norovirus outbreaks occur annually in the U.S., while norovirus continues to cause approximately 685 million cases of acute gastroenteritis globally each year.

The growing demand for rapid syndromic testing in infectious disease diagnostics is supporting market growth due to the need for faster and more comprehensive pathogen detection. Syndromic multiplex PCR panel enables simultaneous identification of multiple pathogens associated with similar clinical symptoms from a single patient sample, reducing diagnostic turnaround time compared with conventional culture-based and single-target testing methods. Healthcare providers are adopting rapid syndromic testing to improve early diagnosis, patient triage, infection control, and treatment selection, particularly in respiratory, gastrointestinal, bloodstream, and central nervous system infections. The growing clinical emphasis on antimicrobial stewardship and reduction of unnecessary antibiotic use is further supporting the adoption of multiplex syndromic molecular diagnostics across hospitals, emergency departments, and clinical laboratories.

Continuous advancements in multiplexing and laboratory automation technologies are driving market growth by improving testing efficiency, workflow automation, and diagnostic accuracy. Innovations in high-plex assay development, automated sample preparation, integrated molecular systems, and real-time data analysis are enabling simultaneous detection of multiple pathogens with faster turnaround times and minimal hands-on time. These technologies also support higher laboratory throughput and improved operational efficiency in clinical settings. For instance, in January 2026, Cepheid received U.S. FDA clearance for the Xpert GI Panel, a multiplex PCR assay designed for simultaneous detection of 11 gastrointestinal bacterial, viral, and parasitic pathogens from a single stool sample. The panel utilizes Cepheid’s 10-color multiplexing technology on GeneXpert systems, supporting rapid syndromic testing and automated molecular diagnostic workflows.

Global Multiplex PCR Panel Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global multiplex PCR panel testing market report based on disease application, end use, throughput, testing setting, and region:

Disease Application Outlook (Revenue, USD Million, 2021-2033)

  • Respiratory Panel
  • Gastrointestinal Panel
  • Sexually Transmitted Infection (STI) Panel
  • Bloodstream / Sepsis Panel
  • Central Nervous System (CNS) Panel
  • Tropical Disease Panel
  • Other Panel

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Clinics (dominant)
  • Diagnostic Laboratories (central labs)
  • Ambulatory Care Centers
  • Academic & Research Institutes
  • Public Health Laboratories
  • Physician Office Labs (POLs)
  • Point-of-Care Settings

Testing Setting Outlook (Revenue, USD Million, 2021-2033)

  • Centralized Laboratory Testing
  • Near-Patient Testing
  • Others

Throughput Outlook (Revenue, USD Million, 2021-2033)

  • Low-throughput systems (POC)
  • Medium-throughput systems
  • High-throughput lab systems

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Application
1.2.2. End Use
1.2.3. Testing Setting
1.2.4. Throughput
1.2.5. Regional
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Multiplex PCR Panel Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of respiratory and gastrointestinal infections
3.2.1.2. Increasing demand for rapid syndromic testing in infectious disease diagnostics
3.2.1.3. Continuous advancements in multiplexing and laboratory automation technologies
3.2.1.4. Growing adoption of decentralized and point-of-care molecular diagnostic platforms
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of multiplex PCR instruments and testing panel
3.2.2.2. Limited reimbursement coverage and regulatory complexities for molecular diagnostic testing
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Multiplex PCR Panel Testing Market: Disease Application Business Analysis
4.1. Disease Application Market Share, 2025 & 2033
4.2. Disease Application Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Disease Application, 2021 to 2033 (USD Million)
4.4. Respiratory Panel
4.4.1. Respiratory Panel Market, 2021 - 2033 (USD Million)
4.5. Gastrointestinal Panel
4.5.1. Gastrointestinal Panel Market, 2021 - 2033 (USD Million)
4.6. Sexually Transmitted Infection (STI) Panel
4.6.1. Sexually Transmitted Infection (STI) Panel Market, 2021 - 2033 (USD Million)
4.7. Bloodstream / Sepsis Panel
4.7.1. Bloodstream / Sepsis Panel Market, 2021 - 2033 (USD Million)
4.8. Central Nervous System (CNS) Panel
4.8.1. Central Nervous System (CNS) Panel Market, 2021 - 2033 (USD Million)
4.9. Tropical Disease Panel
4.9.1. Tropical Disease Panel Market, 2021 - 2033 (USD Million)
4.10. Other Panel
4.10.1. Other Panel Market, 2021 - 2033 (USD Million)
Chapter 5. Multiplex PCR Panel Testing Market: End Use Business Analysis
5.1. End Use Market Share, 2025 & 2033
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
5.4. Hospitals & Clinics
5.4.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
5.5. Diagnostic Laboratories (central labs)
5.5.1. Diagnostic Laboratories (central labs) Market, 2021 - 2033 (USD Million)
5.6. Ambulatory Care Centers
5.6.1. Ambulatory Care Centers Market, 2021 - 2033 (USD Million)
5.7. Academic & Research Institutes
5.7.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
5.8. Public Health Laboratories
5.8.1. Public Health Laboratories Market, 2021 - 2033 (USD Million)
5.9. Physician Office Labs (POLs)
5.9.1. Physician Office Labs (POLs) Market, 2021 - 2033 (USD Million)
5.10. Point-of-Care Settings
5.10.1. Point-of-Care Settings Market, 2021 - 2033 (USD Million)
Chapter 6. Multiplex PCR Panel Testing Market: Testing Setting Business Analysis
6.1. Testing Setting Market Share, 2025 & 2033
6.2. Testing Setting Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Testing Setting, 2021 to 2033 (USD Million)
6.4. Centralized Laboratory Testing
6.4.1. Centralized Laboratory Testing Market, 2021 - 2033 (USD Million)
6.5. Near-Patient Testing
6.5.1. Near-Patient Testing Market, 2021 - 2033 (USD Million)
6.6. Others
6.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. Multiplex PCR Panel Testing Market: Throughput Business Analysis
7.1. Throughput Market Share, 2025 & 2033
7.2. Throughput Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Throughput 2021 to 2033 (USD Million)
7.4. Low-throughput systems (POC)
7.4.1. Low-throughput systems (POC) 2021 - 2033 (USD Million)
7.5. Medium-throughput systems
7.5.1. Medium-throughput systems 2021 - 2033 (USD Million)
7.6. High-throughput lab systems
7.6.1. High-throughput lab systems 2021 - 2033 (USD Million)
Chapter 8. Multiplex PCR Panel Testing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. North America Multiplex PCR Panel Testing Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Framework
8.4.2.5. U.S. Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Framework
8.4.3.5. Canada Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Framework
8.4.4.5. Mexico Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Europe
8.5.1. Europe Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Framework
8.5.2.5. UK Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Framework
8.5.3.5. Germany Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement Framework
8.5.4.5. France Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Target Disease Prevalence
8.5.5.3. Regulatory Framework
8.5.5.4. Reimbursement Framework
8.5.5.5. Italy Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Target Disease Prevalence
8.5.6.3. Regulatory Framework
8.5.6.4. Reimbursement Framework
8.5.6.5. Spain Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Target Disease Prevalence
8.5.7.3. Regulatory Framework
8.5.7.4. Reimbursement Framework
8.5.7.5. Denmark Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Target Disease Prevalence
8.5.8.3. Regulatory Framework
8.5.8.4. Reimbursement Framework
8.5.8.5. Sweden Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Target Disease Prevalence
8.5.9.3. Regulatory Framework
8.5.9.4. Reimbursement Framework
8.5.9.5. Norway Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Framework
8.6.2.5. Japan Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Framework
8.6.3.5. China Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Framework
8.6.4.5. India Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Framework
8.6.5.5. Australia Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Regulatory Framework
8.6.6.4. Reimbursement Framework
8.6.6.5. South Korea Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Target Disease Prevalence
8.6.7.3. Regulatory Framework
8.6.7.4. Reimbursement Framework
8.6.7.5. Thailand Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Latin America
8.7.1. Latin America Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Target Disease Prevalence
8.7.2.3. Regulatory Framework
8.7.2.4. Reimbursement Framework
8.7.2.5. Brazil Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Target Disease Prevalence
8.7.3.3. Regulatory Framework
8.7.3.4. Reimbursement Framework
8.7.3.5. Argentina Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. Middle East and Africa
8.8.1. Middle East and Africa Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Target Disease Prevalence
8.8.2.3. Regulatory Framework
8.8.2.4. Reimbursement Framework
8.8.2.5. South Africa Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Target Disease Prevalence
8.8.3.3. Regulatory Framework
8.8.3.4. Reimbursement Framework
8.8.3.5. Saudi Arabia Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Target Disease Prevalence
8.8.4.3. Regulatory Framework
8.8.4.4. Reimbursement Framework
8.8.4.5. UAE Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Target Disease Prevalence
8.8.5.3. Regulatory Framework
8.8.5.4. Reimbursement Framework
8.8.5.5. Kuwait Multiplex PCR Panel Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. F. Hoffmann-La Roche Ltd.
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. bioMerieux SA
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. QIAGEN N.V.
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. Thermo Fisher Scientific Inc.
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. DiaSorin S.p.A
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Abbott
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. BD
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. AusDiagnostics
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Bio-Rad Laboratories Inc.
9.5.9.1. Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. Cepheid
9.5.10.1. Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global multiplex PCR panel testing market, by region, 2021 - 2033 (USD Million)
Table 4 Global multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 5 Global multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 6 Global multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 7 Global multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 8 North America multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
Table 9 North America multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 10 North America multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 11 North America multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 12 North America multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 13 U.S multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 14 U.S multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 15 U.S multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 16 U.S multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 17 Canada multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 18 Canada multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 19 Canada multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 20 Canada multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 21 Mexico multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 22 Mexico multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 23 Mexico multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 24 Mexico multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 25 Europe multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
Table 26 Europe multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 27 Europe multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 28 Europe multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 29 Europe multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 30 UK multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 31 UK multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 32 UK multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 33 UK multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 34 Germany multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 35 Germany multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 36 Germany multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 37 Germany multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 38 France multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 39 France multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 40 France multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 41 France multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 42 Italy multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 43 Italy multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 44 Italy multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 45 Italy multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 46 Spain multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 47 Spain multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 48 Spain multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 49 Spain multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 50 Norway multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 51 Norway multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 52 Norway multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 53 Norway multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 54 Denmark multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 55 Denmark multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 56 Denmark multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 57 Denmark multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 58 Sweden multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 59 Sweden multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 60 Sweden multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 61 Sweden multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 62 Asia Pacific multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 64 Asia Pacific multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 65 Asia Pacific multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 66 Asia Pacific multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 67 Japan multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 68 Japan multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 69 Japan multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 70 Japan multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 71 China multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 72 China multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 73 China multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 74 China multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 75 India multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 76 India multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 77 India multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 78 India multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 79 Australia multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 80 Australia multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 81 Australia multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 82 Australia multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 83 South Korea multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 84 South Korea multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 85 South Korea multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 86 South Korea multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 87 Thailand multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 88 Thailand multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 89 Thailand multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 90 Thailand multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 91 Latin America multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
Table 92 Latin America multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 93 Latin America multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 94 Latin America multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 95 Latin America multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 96 Brazil multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 97 Brazil multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 98 Brazil multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 99 Brazil multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 100 Argentina multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 101 Argentina multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 102 Argentina multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 103 Argentina multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 104 Middle East & Africa multiplex PCR panel testing market, by country, 2021 - 2033 (USD Million)
Table 105 Middle East & Africa multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 106 Middle East & Africa multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 107 Middle East & Africa multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 108 Middle East & Africa multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 109 South Africa multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 110 South Africa multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 111 South Africa multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 112 South Africa multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 117 UAE multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 118 UAE multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 119 UAE multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 120 UAE multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
Table 121 Kuwait multiplex PCR panel testing market, by disease application, 2021 - 2033 (USD Million)
Table 122 Kuwait multiplex PCR panel testing market, by end-use, 2021 - 2033 (USD Million)
Table 123 Kuwait multiplex PCR panel testing market, by testing setting, 2021 - 2033 (USD Million)
Table 124 Kuwait multiplex PCR panel testing market, by throughput, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Multiplex PCR panel testing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape
Fig. 10 Multiplex PCR panel testing market dynamics
Fig. 11 Multiplex PCR panel testing market: Porter’s five forces analysis
Fig. 12 Multiplex PCR panel testing market: PESTLE analysis
Fig. 13 Multiplex PCR panel testing market: Disease application movement analysis)
Fig. 14 Respiratory panel market, 2021 - 2033 (USD Million)
Fig. 15 Gastrointestinal panel market, 2021 - 2033 (USD Million)
Fig. 16 Sexually transmitted infection (STI) Panel market, 2021 - 2033 (USD Million)
Fig. 17 Bloodstream / Sepsis Panel market, 2021 - 2033 (USD Million)
Fig. 18 Central Nervous System (CNS) Panel market, 2021 - 2033 (USD Million)
Fig. 19 Tropical Disease Panel market, 2021 - 2033 (USD Million)
Fig. 20 Other Panel market, 2021 - 2033 (USD Million)
Fig. 21 Multiplex PCR panel testing market: End use movement analysis)
Fig. 22 Hospitals & Clinics market, 2021 - 2033 (USD Million)
Fig. 23 Diagnostic Laboratories (central labs) market, 2021 - 2033 (USD Million)
Fig. 24 Ambulatory Care Centers market, 2021 - 2033 (USD Million)
Fig. 25 Academic & Research Institutes market, 2021 - 2033 (USD Million)
Fig. 26 Public Health Laboratories market, 2021 - 2033 (USD Million)
Fig. 27 Physician Office Labs (POLs) market, 2021 - 2033 (USD Million)
Fig. 28 Point-of-Care Settings market, 2021 - 2033 (USD Million)
Fig. 29 Multiplex PCR panel testing market: Setting location movement analysis
Fig. 30 Centralized Laboratory Testing market, 2021 - 2033 (USD Million)
Fig. 31 Near-Patient Testing market, 2021 - 2033 (USD Million)
Fig. 32 Others market, 2021 - 2033 (USD Million)
Fig. 33 Multiplex PCR panel testing market: Throughput movement analysis
Fig. 34 Low-throughput systems (POC) market, 2021 - 2033 (USD Million)
Fig. 35 Medium-throughput systems market, 2021 - 2033 (USD Million)
Fig. 36 High-throughput lab systems market, 2021 - 2033 (USD Million)
Fig. 37 Regional marketplace: Key takeaways
Fig. 38 North America Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 39 U.S. country dynamics
Fig. 40 U.S. Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 41 Canada country dynamics
Fig. 42 Canada Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 43 Mexico country dynamics
Fig. 44 Mexico Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 45 Europe Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 46 UK country dynamics
Fig. 47 UK Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 48 Germany country dynamics
Fig. 49 Germany Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 50 France country dynamics
Fig. 51 France Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 52 Italy country dynamics
Fig. 53 Italy Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 54 Spain country dynamics
Fig. 55 Spain Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 56 Norway country dynamics
Fig. 57 Norway Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 58 Sweden country dynamics
Fig. 59 Sweden Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 60 Denmark country dynamics
Fig. 61 Denmark Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 62 Asia Pacific Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 63 Japan country dynamics
Fig. 64 Japan Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 65 China country dynamics
Fig. 66 China Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 67 India country dynamics
Fig. 68 India Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 69 Australia country dynamics
Fig. 70 Australia Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 71 South Korea country dynamics
Fig. 72 South Korea Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 73 Thailand country dynamics
Fig. 74 Thailand Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 75 Latin America Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 76 Brazil country dynamics
Fig. 77 Brazil Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 78 Argentina country dynamics
Fig. 79 Argentina Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 80 MEA Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 81 South Africa country dynamics
Fig. 82 South Africa Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 83 Saudi Arabia country dynamics
Fig. 84 Saudi Arabia Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 85 UAE country dynamics
Fig. 86 UAE Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 87 Kuwait country dynamics
Fig. 88 Kuwait Multiplex PCR panel testing market, 2021 - 2033 (USD Million)
Fig. 89 Company categorization
Fig. 90 Company market position analysis
Fig. 91 Strategic framework

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • bioMérieux SA
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • DiaSorin S.p.A
  • Abbott
  • BD
  • AusDiagnostics
  • Bio-Rad Laboratories, Inc.
  • Cepheid

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 2.58 Billion
Forecasted Market Value ( USD ) by 2033 $ 4.86 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

U.S. Point of Care Molecular Diagnostics Market Size, Share & Trends Analysis Report By Test Location (OTC, POC), By Application (Infectious Diseases, Oncology, Prenatal Testing), By Technology, By End-use (Decentralized Labs, Hospitals), And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Point of Care Molecular Diagnostics Market Size, Share & Trends Analysis Report By Test Location (OTC, POC), By Application (Infectious Diseases, Oncology, Prenatal Testing), By Technology, By End-use (Decentralized Labs, Hospitals), And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • United States
From
Real-Time PCR, Digital PCR, and End-Point PCR Market Size, Share & Trends Analysis Report by Technology, Product, Application, Region, and Growth Forecasts, 2026-2033 - Product Image

Real-Time PCR, Digital PCR, and End-Point PCR Market Size, Share & Trends Analysis Report by Technology, Product, Application, Region, and Growth Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
India Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents & Consumables), Test Location, Technology, Platform, Application, End Use with Growth Forecasts, 2025-2033 - Product Image

India Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents & Consumables), Test Location, Technology, Platform, Application, End Use with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • India
From
U.S. STI & Vaginitis PCR Testing Market Size, Share & Trends Analysis Report By Condition (Sexually Transmitted Infections (STIs), Vaginal Infections), By Test Type, By End Use, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. STI & Vaginitis PCR Testing Market Size, Share & Trends Analysis Report By Condition (Sexually Transmitted Infections (STIs), Vaginal Infections), By Test Type, By End Use, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • United States
From
North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030 - Product Image

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • North America
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.